Efficacy of three methods in the treatment of androgenic alopecia
Phase 3
- Conditions
- Androgenic alopecia.male-pattern baldness
- Registration Number
- IRCT138902081159N3
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 44
Inclusion Criteria
Inclusion Criteria:
Men with androgenic alopecia referred to Skin and Stem Cell Research Center Clinics who are not willing to do hair transplantation
Exclusion Criteria
1- History of allergy or sensitivity to finastride
2- Abnormal findings in physical examination or hormonal tests
3- History of taking finastride or other 5- alfa reductase inhibitors within last 12 months
4- History of taking antiandrogenic drugs or minoxidil application during past 6 months
5- Lack of cooperation of patients or unwilling for participating in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hair diameter. Timepoint: Before intervention and every three months after intervention. Method of measurement: trichoscan.;Hair Density. Timepoint: Before intervention and every three months after intervention. Method of measurement: trichoscan.;Patient satisfaction. Timepoint: 3,6,9 and 12 months after treatment. Method of measurement: VAS(0-10).;Physician rating scale. Timepoint: 3,6,9 and 12 months after treatment. Method of measurement: 0-7.
- Secondary Outcome Measures
Name Time Method Side effects of treatment. Timepoint: 3, 6, 9 and 12 months after treatment. Method of measurement: check list.